Nasdaq Markets

Key PointsWarren Buffett retired as Berkshire’s CEO on Dec. 31, giving Abel full control over day-to-day operations and the company’s $356 billion investment portfolio.

Early indicators point to a weaker 2026 iPhone sales cycle.

Key PointsPNC Financial increased its dividend 18% in Q3.

(RTTNews) - European stocks eked out modest gains on Wednesday as investors cheered strong results from ASML and awaited the release of U.S. CPI data later in the day for additional clues on the Federal Reserve's rate trajectory.

Key PointsZcash is not a lottery ticket, but rather an investment for the long term.

Key PointsThiel Macro, an investment company run by Peter Thiel, had 42% of its portfolio invested in Amazon and Vistra Energy as of the second quarter.

Key PointsNextEra's dividend appears sustainable based on its projected earnings.

(RTTNews) - Asian stocks ended mostly lower on Wednesday, even as pressure on tech stocks eased and dovish Fed remarks spurred expectations that the U.S. Federal Reserve may not need to raise interest rates aggressively next year.

Key PointsNew CEO John Ternus plans to take a more hands-on role with design.

Key PointsThe summer stock market was livelier than many expected it to be.

Key PointsThe Bureau of Labor Statistics will release the September inflation report today, Oct. 14.

Key PointsBuffett warned 25 years ago about a specific stock market scenario.

Key PointsA dozen cryptocurrencies have posted returns of 100% or higher during the past three months.

Key PointsMicron has now inked a total of 26 strategic customer agreements that provide long-term pricing frameworks, up from 16 three months ago.

(RTTNews) - Nxera Pharma Co., Ltd. (4565.T), a technology-powered biopharmaceutical company, on Wednesday announced an exclusive licensing, supply and commercialization agreement with Synmosa Biopharma Corp. (4114.TWO).

Key PointsThe Vanguard Morningstar Value ETF has gained around 18% in 2026, topping the growth fund's 13%.

Key PointsNike's sales fell 4% in the latest fiscal quarter, with Greater China down 22%.

Key PointsMicron's annual report shows no customer made up 10% or more of its revenue in fiscal 2026.

(RTTNews) - On Wednesday, Pharming Group N.V. (PHAR) announced positive topline results from a Phase II study evaluating Leniolisib in patients with genetically identifiable primary immunodeficiencies (PIDs) associated with immune dysregulation linked to altered PI3Kdelta signa

Key PointsWD-40 has raised its dividend for 10 consecutive years, backed by a product with minimal real competition.